NF1‐09 presents MPNST genetic features such as the inactivation of NF1, CDKN2A, and also TP53, but with PRC2 active and an activating mutation in the PIK3CA gene. The gene discussed is NF1; the disease is malignant peripheral nerve sheath tumor.